Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds.

Alex W. Hewitt(Lions Eye Institute), Mary K. Wirtz(Legacy Health), Irma Järvelä(University of Helsinki), Paul R. Lichter(University of Michigan–Ann Arbor), George Kitsos(University of Ioannina), David A. Mackey(Lions Eye Institute), Janey L. Wiggs(Massachusetts Eye and Ear Infirmary), Julia E. Richards(University of Michigan–Ann Arbor), Subbaiah Ramasamy Krishnadas(Aravind Eye Hospital), R. Rand Allingham(Duke Medical Center), Michael B. Petersen(Institute of Child Health), John R. Samples(Rocky Vista University), Periasamy Sundaresan(Aravind Eye Hospital)
PubMed
March 28, 2007
Cited by 14


Related Papers